Archives

by in
Entry Author Date Location
East Coast Life Sciences Roundup: Termeer, Atlas, OSI Pharma & More 05/17/13 Boston
Ensysce’s Bet: Combining Two Risky Drug Technologies That Add Up 05/09/13 Texas
Some Bold Baseball and Biotech Picks for the 2013 Season 03/11/13 National
Shedding Baggage, Alnylam Turns a Corner 02/21/13 Boston
East Coast Life Sciences Roundup: Biogen Idec, Celgene, Alnylam, More 02/08/13 Boston
RNA Therapeutics Are Coming of Age 02/08/13 San Diego
Alnylam Gets $25M From Medicines Co. for Cholesterol Drug 02/04/13 Boston
East Coast Life Sciences Roundup: Aveo, Mayo Clinic, GI Dynamics, More 01/18/13 Boston
Alnylam, Lawsuit Settled, Announces $125 Million Stock Offering 01/15/13 Boston
Alnylam, Tekmira Look Ahead After RNAi Divorce 11/14/12 Boston
Alnylam to Pay Tekmira $65M to Settle RNAi Delivery Dispute 11/12/12 Boston
Who Are Biotech’s New Go-To Investment Bankers? 11/12/12 National
Alnylam Gets $22.5M From Genzyme for Asia Rights to Amyloidosis Drug 10/22/12 Boston
San Diego Life Sciences Roundup: Regulus IPO, Fate Funding, & More 08/23/12 San Diego
Regulus Therapeutics Files for IPO as ‘Emerging Growth’ Company 08/20/12 San Diego
Brace Yourself: Biotech IPOs Are Beating Tech’s Big Names 08/13/12 National
Alnylam, Galenea, Gen9, & More from the Boston Life Sciences Roundup 07/20/12 Boston
Alnylam Stock Climbs on Positive Early Trial for Amyloidosis 07/16/12 Boston
Join Us for BIO Tweetchat at 12:30 pm ET with John Maraganore 06/15/12 National
What Are the Hottest Targets in Biotech Today? 04/23/12 National
AIDS Drugs Were the Start. Let’s See More FDA Accelerated Approvals 03/12/12 National
Reinventing Biotech: Meet Corey Goodman, Kevin Starr & More April 3 02/23/12 Seattle
Alnylam Cuts One-Third of Workforce, To Save Cash for RNAi Clinical Plans 01/19/12 Boston
Join Kevin Starr, Corey Goodman, Carl Weissman & More in Seattle April 3 01/19/12 Seattle
Biology 101 01/18/12 Boston
Alnylam, Aveo, Biogen, & More Boston Life Sciences Newsmakers 01/06/12 Boston
Alnylam Gets First Hint of Effectiveness for RNAi Cholesterol-Lowering Drug 01/04/12 Boston
Vertex, Ariad, Alnylam, & More Boston-Area Life Sciences Newsmakers 12/16/11 Boston
Alnylam Racing to Prove RNAi Works, For a Disease You’ve Never Heard Of 12/13/11 Boston
Langer Nabs Cash From Rock Stars, Verastem Seeks $50M IPO, Alnylam Snags RNAi Collab, & More Boston-Area Life Sciences News 11/04/11 Boston
Page 1 of 8 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.